IsoRay, Inc. (ISR) Financial Statements (2023 and Earlier)
Company Profile
| Business Address |
350 HILLS STREET, RICHLAND, WA 99354 |
| State of Incorp. | MN |
| Fiscal Year End | June 30 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2021 TTM | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 60,354 | 63,828 | 2,392 | 5,326 | 3,425 | 8,971 | 12,386 | ||
| Cash and cash equivalents | 60,354 | 63,828 | 2,392 | 5,326 | 2,600 | 5,932 | 10,139 | ||
| Short-term investments | 825 | 3,039 | 2,247 | ||||||
| Receivables | 1,647 | 2,013 | 2,044 | 1,154 | 1,192 | 726 | 605 | ||
| Inventory, net of allowances, customer advances and progress billings | 1,068 | 980 | 645 | 530 | 494 | 323 | 334 | ||
| Inventory | 1,068 | 980 | 645 | 530 | 494 | 323 | 334 | ||
| Prepaid expense | 443 | 382 | 201 | 274 | 185 | 277 | |||
| Other current assets | 27 | 27 | 27 | 29 | 30 | 27 | |||
| Other undisclosed current assets | 535 | 11 | 17 | 77 | 32 | 56 | 0 | ||
| Total current assets: | 63,604 | 67,302 | 5,507 | 7,315 | 5,446 | 10,291 | 13,629 | ||
| Noncurrent Assets | |||||||||
| Inventory, Noncurrent | 741 | 76 | 137 | 155 | 319 | 513 | 591 | ||
| Operating lease, right-of-use asset | 642 | 768 | 1,001 | ✕ | ✕ | ✕ | ✕ | ||
| Property, plant and equipment | 1,973 | 1,958 | 1,735 | 1,609 | 1,311 | 1,054 | 577 | ||
| Long-term investments and receivables | 2,973 | ||||||||
| Long-term investments | 2,973 | ||||||||
| Restricted cash and investments | 182 | 182 | 181 | 181 | 181 | 181 | 181 | ||
| Other noncurrent assets | 110 | 130 | 138 | 162 | 198 | 230 | 151 | ||
| Total noncurrent assets: | 3,648 | 3,114 | 3,192 | 2,107 | 2,009 | 1,978 | 4,473 | ||
| TOTAL ASSETS: | 67,252 | 70,416 | 8,699 | 9,422 | 7,455 | 12,269 | 18,102 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities, including: | 847 | 730 | 654 | 683 | 1,391 | 630 | 611 | ||
| Employee-related liabilities | 259 | 259 | 204 | 142 | 155 | 138 | 72 | ||
| Other undisclosed accounts payable and accrued liabilities | 588 | 471 | 450 | 541 | 1,236 | 492 | 538 | ||
| Other liabilities | 103 | 100 | 94 | 74 | 37 | 125 | 177 | ||
| Other undisclosed current liabilities | 895 | 971 | 827 | 364 | 407 | 351 | 306 | ||
| Total current liabilities: | 1,845 | 1,801 | 1,575 | 1,121 | 1,835 | 1,106 | 1,093 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 392 | 524 | 769 | ||||||
| Operating lease, liability | 392 | 524 | 769 | ✕ | ✕ | ✕ | ✕ | ||
| Liabilities, other than long-term debt | 624 | 608 | 577 | 621 | 590 | 561 | 607 | ||
| Asset retirement obligations | 624 | 608 | 577 | 621 | 590 | 561 | 580 | ||
| Derivative instruments and hedges, liabilities | 27 | ||||||||
| Other undisclosed noncurrent liabilities | 77 | 55 | |||||||
| Total noncurrent liabilities: | 1,016 | 1,209 | 1,401 | 621 | 590 | 561 | 607 | ||
| Total liabilities: | 2,861 | 3,010 | 2,976 | 1,742 | 2,425 | 1,667 | 1,701 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 64,391 | 67,406 | 5,723 | 7,680 | 5,030 | 10,602 | 16,401 | ||
| Common stock | 142 | 142 | 69 | 67 | 56 | 55 | 55 | ||
| Additional paid in capital | 159,421 | 158,589 | 93,592 | 92,105 | 84,322 | 83,151 | 82,788 | ||
| Accumulated deficit | (95,172) | (91,325) | (87,938) | (84,492) | (79,348) | (72,604) | (66,442) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | ||||||||
| Total stockholders' equity: | 64,391 | 67,406 | 5,723 | 7,680 | 5,030 | 10,602 | 16,401 | ||
| TOTAL LIABILITIES AND EQUITY: | 67,252 | 70,416 | 8,699 | 9,422 | 7,455 | 12,269 | 18,102 | ||
Income Statement (P&L) ($ in thousands)
| 12/31/2021 TTM | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 10,690 | 10,053 | 9,680 | 7,314 | 5,923 | 4,761 | 4,769 | |
| Revenue, net | ✕ | ✕ | ✕ | ✕ | 4,761 | 4,769 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (5,733) | (4,932) | (4,556) | (4,267) | (4,081) | (3,923) | (4,640) | |
| Gross profit: | 4,957 | 5,121 | 5,124 | 3,047 | 1,842 | 838 | 129 | |
| Operating expenses | (10,725) | (8,567) | (8,600) | (8,301) | (8,571) | (7,145) | (5,211) | |
| Operating loss: | (5,768) | (3,446) | (3,476) | (5,254) | (6,729) | (6,307) | (5,082) | |
| Nonoperating income | 115 | 59 | 30 | 110 | 29 | 145 | 371 | |
| Investment income, nonoperating | 115 | 59 | 30 | 108 | 29 | 118 | 218 | |
| Interest and debt expense | (1) | |||||||
| Net loss: | (5,653) | (3,387) | (3,446) | (5,144) | (6,700) | (6,162) | (4,712) | |
| Other undisclosed net income attributable to parent | 1 | |||||||
| Net loss attributable to parent: | (5,653) | (3,387) | (3,446) | (5,144) | (6,700) | (6,162) | (4,711) | |
| Preferred stock dividends and other adjustments | (3) | (11) | (11) | (11) | (11) | (11) | ||
| Net loss available to common stockholders, diluted: | (5,653) | (3,390) | (3,457) | (5,155) | (6,711) | (6,173) | (4,721) | |
Comprehensive Income ($ in thousands)
| 12/31/2021 TTM | 6/30/2021 | 6/30/2020 | 6/30/2019 | 6/30/2018 | 6/30/2017 | 6/30/2016 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (5,653) | (3,387) | (3,446) | (5,144) | (6,700) | (6,162) | (4,712) | |
| Comprehensive loss, net of tax, attributable to parent: | (5,653) | (3,387) | (3,446) | (5,144) | (6,700) | (6,162) | (4,712) | |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.